Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Δ9-tetrahydrocannabinol in C57BL/6J mice

[1] Abadji V(1994)( J Med Chem 37 1889-1893

[2] Lin S(1992))-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability Neurosci Biobehav Rev 16 55-62

[3] Taha G(2004)Δ J Pharmacol Exp Ther 309 86-91

[4] Griffin G(2000)-tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication Psychopharmacology 153 67-84

[5] Stevenson LA(1997)Differential effects of Δ Exp Clin Psychopharmacol 5 195-202

[6] Pertwee RG(1988)-tetrahydrocannabinol and methanandamide in CB Psychopharmacology 94 206-212

[7] Makriyannis A(2006) knockout and wild-type mice AAPS J 8 E112-E117

[8] Balster RL(1992)Agonist efficacy, drug dependence, and medications development: preclinical evaluation of opioid, dopaminergic, and GABA J Pharmacol Exp Ther 263 1118-1126

[9] Prescott WR(2004)-ergic ligands Behav Pharmacol 15 1-12

[10] Baskfield CY(1993)( Biochem Pharmacol 46 791-796

[1] Abadji V(1994)( J Med Chem 37 1889-1893

[2] Lin S(1992))-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability Neurosci Biobehav Rev 16 55-62

[3] Taha G(2004)Δ J Pharmacol Exp Ther 309 86-91

[4] Griffin G(2000)-tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication Psychopharmacology 153 67-84

[5] Stevenson LA(1997)Differential effects of Δ Exp Clin Psychopharmacol 5 195-202

[6] Pertwee RG(1988)-tetrahydrocannabinol and methanandamide in CB Psychopharmacology 94 206-212

[7] Makriyannis A(2006) knockout and wild-type mice AAPS J 8 E112-E117

[8] Balster RL(1992)Agonist efficacy, drug dependence, and medications development: preclinical evaluation of opioid, dopaminergic, and GABA J Pharmacol Exp Ther 263 1118-1126

[9] Prescott WR(2004)-ergic ligands Behav Pharmacol 15 1-12

[10] Baskfield CY(1993)( Biochem Pharmacol 46 791-796